| Product Code: ETC7356595 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Greece Pneumococcal Vaccine Market Overview |
3.1 Greece Country Macro Economic Indicators |
3.2 Greece Pneumococcal Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Greece Pneumococcal Vaccine Market - Industry Life Cycle |
3.4 Greece Pneumococcal Vaccine Market - Porter's Five Forces |
3.5 Greece Pneumococcal Vaccine Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Greece Pneumococcal Vaccine Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Greece Pneumococcal Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Greece Pneumococcal Vaccine Market Revenues & Volume Share, By End Users, 2021 & 2031F |
3.9 Greece Pneumococcal Vaccine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Greece Pneumococcal Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in preventing pneumococcal diseases. |
4.2.2 Government initiatives to promote vaccination programs and improve healthcare infrastructure. |
4.2.3 Rising prevalence of pneumococcal diseases in Greece. |
4.3 Market Restraints |
4.3.1 High cost associated with pneumococcal vaccines. |
4.3.2 Limited access to vaccination services in rural or remote areas. |
4.3.3 Concerns about the safety and efficacy of pneumococcal vaccines among some population segments. |
5 Greece Pneumococcal Vaccine Market Trends |
6 Greece Pneumococcal Vaccine Market, By Types |
6.1 Greece Pneumococcal Vaccine Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Greece Pneumococcal Vaccine Market Revenues & Volume, By Vaccine Type, 2021- 2031F |
6.1.3 Greece Pneumococcal Vaccine Market Revenues & Volume, By Pneumococcal Conjugate Vaccine, 2021- 2031F |
6.1.4 Greece Pneumococcal Vaccine Market Revenues & Volume, By Pneumococcal Polysaccharide Vaccine, 2021- 2031F |
6.2 Greece Pneumococcal Vaccine Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Greece Pneumococcal Vaccine Market Revenues & Volume, By Prevnar 13, 2021- 2031F |
6.2.3 Greece Pneumococcal Vaccine Market Revenues & Volume, By Synflorix, 2021- 2031F |
6.2.4 Greece Pneumococcal Vaccine Market Revenues & Volume, By Pneumovax 23, 2021- 2031F |
6.2.5 Greece Pneumococcal Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Greece Pneumococcal Vaccine Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Greece Pneumococcal Vaccine Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.3.3 Greece Pneumococcal Vaccine Market Revenues & Volume, By Intramuscular, 2021- 2031F |
6.3.4 Greece Pneumococcal Vaccine Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.4 Greece Pneumococcal Vaccine Market, By End Users |
6.4.1 Overview and Analysis |
6.4.2 Greece Pneumococcal Vaccine Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Greece Pneumococcal Vaccine Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 Greece Pneumococcal Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Greece Pneumococcal Vaccine Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Greece Pneumococcal Vaccine Market Revenues & Volume, By Distribution Partner Companies, 2021- 2031F |
6.5.3 Greece Pneumococcal Vaccine Market Revenues & Volume, By Non-governmental Organizations (NGO), 2021- 2031F |
6.5.4 Greece Pneumococcal Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
7 Greece Pneumococcal Vaccine Market Import-Export Trade Statistics |
7.1 Greece Pneumococcal Vaccine Market Export to Major Countries |
7.2 Greece Pneumococcal Vaccine Market Imports from Major Countries |
8 Greece Pneumococcal Vaccine Market Key Performance Indicators |
8.1 Vaccination coverage rate among vulnerable populations. |
8.2 Number of public health campaigns promoting pneumococcal vaccination. |
8.3 Percentage of healthcare facilities offering pneumococcal vaccines. |
8.4 Rate of pneumococcal disease incidence in Greece. |
8.5 Number of reported adverse events following pneumococcal vaccination. |
9 Greece Pneumococcal Vaccine Market - Opportunity Assessment |
9.1 Greece Pneumococcal Vaccine Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Greece Pneumococcal Vaccine Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Greece Pneumococcal Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Greece Pneumococcal Vaccine Market Opportunity Assessment, By End Users, 2021 & 2031F |
9.5 Greece Pneumococcal Vaccine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Greece Pneumococcal Vaccine Market - Competitive Landscape |
10.1 Greece Pneumococcal Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Greece Pneumococcal Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here